Table 9.12a

Unadjusted Patient Survival, Deceased Donor Liver Transplants

Survival at 3 Months, 1 Year, 3 Years, and 5 Years

  3 Months 1 Year 3 Years 5 Years
(Tx 2002 - 2003) (Tx 2002 - 2003) (Tx 2000 - 2003) (Tx 1998 - 2003)
N % Std. Err. N % Std. Err. N % Std. Err. N % Std. Err.
Total All 8,879 93.0% 0.3% 8,879 86.8% 0.4% 16,846 79.1% 0.4% 24,621 73.1% 0.3%
Primary Diagnosis Non-Cholestatic Cirrhosis 5,615 93.3% 0.3% 5,615 86.5% 0.5% 10,984 78.2% 0.4% 16,183 71.4% 0.4%
Cholestatic Liver Disease/Cirrhosis 852 94.5% 0.8% 852 90.7% 1.0% 1,664 85.0% 1.0% 2,580 80.4% 0.9%
Acute Hepatic Necrosis 629 87.4% 1.3% 629 80.9% 1.6% 1,329 74.6% 1.3% 1,964 71.0% 1.2%
Biliary Atresia 295 93.9% 1.4% 295 92.2% 1.6% 582 90.5% 1.3% 911 86.7% 1.2%
Metabolic Diseases 297 94.9% 1.3% 297 91.2% 1.6% 588 86.0% 1.6% 858 81.9% 1.5%
Malignant Neoplasms 603 94.0% 1.0% 603 86.4% 1.4% 789 70.5% 2.4% 959 60.1% 2.6%
Other 588 91.8% 1.1% 588 86.1% 1.4% 910 80.1% 1.5% 1,166 72.4% 1.8%


Source: OPTN/SRTR Data as of May 2, 2005.

(+) = Values not determined due to insufficient follow-up.

(-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during the years listed at the top of the table.

Patient survival follows patients from first transplant of this type until death.Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on liver transplants.

Multi-organ transplants are excluded.